Law360, New York (January 30, 2009) -- A federal district judge has rejected Forest Laboratories Inc.'s second bid to toss one of Caraco Pharmaceutical Laboratories Ltd.'s declaratory actions against the company over a patent for the depression treatment Lexapro.
Judge Bernard A. Friedman of the U.S. District Court for the Eastern District of Michigan rejected Forest's latest motion to dismiss the case Thursday....
